Clinical Trial Update: The Fructose and Allulose Catalytic Effects (FACE) Trial [NA]

View source ↗

Summary

The FACE trial, sponsored by the University of Toronto, investigating the catalytic effects of fructose and allulose in Type 2 Diabetes, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Allulose (allulose)
• Fructose (fructose)

Snippet

Sponsor: University of Toronto | Conditions: Type 2 Diabetes | NA | Status: COMPLETED